XML 26 R17.htm IDEA: XBRL DOCUMENT
v3.22.1

EARNINGS PER SHARE | 3 Months Ended
--- | ---
Mar. 31, 2022
EARNINGS PER SHARE |
EARNINGS PER SHARE | 11. EARNINGS PER SHARE The following represents the calculation of earnings (loss) per share (in thousands, except per share amounts): ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended
​ | ​ | March 31,
​ | ​ | 2022 | ​ | 2021
Basic: | ​ | ​ | ​ | ​ | ​ | ​
Net income (loss) | ​ | $ | (92,744) | ​ | $ | (33,375)
Weighted average basic number of common shares outstanding | ​ | ​ | 16,303 | ​ | ​ | 16,232
Basic net income (loss) per share of common stock | ​ | $ | (5.69) | ​ | $ | (2.06)
​ | ​ | ​ | ​ | ​ | ​ | ​
Diluted: | ​ | ​ | ​ | ​ | ​ | ​
Net income (loss) | ​ | $ | (92,744) | ​ | $ | (33,375)
Weighted average basic number of common shares outstanding | ​ | ​ | 16,303 | ​ | ​ | 16,232
Common stock equivalent shares representing shares issuable upon: | ​ | ​ | ​ | ​ | ​ | ​
Exercise of Series A Warrants | ​ | ​ | Anti-dilutive | ​ | ​ | Anti-dilutive
Exercise of Series B Warrants | ​ | ​ | Anti-dilutive | ​ | ​ | Anti-dilutive
Exercise of Series C Warrants | ​ | ​ | Anti-dilutive | ​ | ​ | Anti-dilutive
Exercise of stock options | ​ | ​ | Anti-dilutive | ​ | ​ | Anti-dilutive
Vesting of restricted stock units | ​ | ​ | Anti-dilutive | ​ | ​ | Anti-dilutive
Weighted average diluted number of common shares outstanding | ​ | ​ | 16,303 | ​ | ​ | 16,232
Diluted net income (loss) per share of common stock | ​ | $ | (5.69) | ​ | $ | (2.06)
​ Common stock equivalents, including warrants, options and restricted stock units, totaling 7.7 million for the three months ended March 31, 2022 were not included in the computation of diluted earnings per share of common stock because the effect would have been anti-dilutive due to the net loss. Common stock equivalents, including warrants, options and restricted stock units, totaling 7.8 million for the three months ended March 31, 2021 were not included in the computation of diluted earnings per share of common stock because the effect would have been anti-dilutive due to the net loss.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI http://asc.fasb.org/topic&trid=2144383 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration